Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1
Publication information:
Pery, Sheehy, Nebane M, Misra, Mankowski M, Rasmussen, White L, Ptak R, Gabuzda. Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1.
Virology. 2015;484:276–87.